Trials / Sponsors / Inventiva Pharma
Inventiva Pharma
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Co NASH - Nonalcoholic Steatohepatitis, Diabetes Mellitus, Type 2 | Phase 2 | 2022-06-29 |
| Active Not Recruiting | A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Ad NASH - Nonalcoholic Steatohepatitis | Phase 3 | 2021-08-19 |
| Completed | Multiple Ascending Dose Phase I Study in Order to Define Lanifibranor (IVA337) Supra-thjerapeutic Dose Healthy Subjects | Phase 1 | 2019-01-17 |
| Completed | A Study in MPS VI to Assess Safety and Efficacy of Odiparcil Mucopolysaccharidosis VI | Phase 2 | 2017-12-30 |
| Completed | Phase 2b Study in NASH to Assess IVA337 Non-Alcoholic Steatohepatitis (NASH) | Phase 2 | 2017-02-07 |
| Completed | Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis Scleroderma, Diffuse, Diffuse Cutaneous Systemic Sclerosis | Phase 2 | 2015-10-29 |